Health Canada approved Pfizer-BioNTech’s updated COVID-19 vaccine on Tuesday, marking its third authorization of vaccine formulations that protect against the most recently circulating variants of the virus.

Pfizer-BioNTech’s mRNA vaccine, called Comirnaty, targets the KP.2 subvariant of Omicron, replacing the previous version that targeted the XBB.1.5 Omicron subvariant.

The timelines for when people can get the new shots is up to the provinces and territories, the Public Health Agency of Canada said{ai:summary}<p>Health Canada approved an updated COVID-19 vaccine from Pfizer-BioNTech, known as Comirnaty, which is designed to protect against the KP.2 subvariant of Omicron. This marks the third authorization for vaccines targeting recent variants.</p><p>#health</p>

Updated Pfizer-BioNTech’s COVID-19 vaccine approved by Health Canada

Loading...